OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neurology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Prevalence of infratentorial superficial siderosis in a large general population sample from the UK Biobank	140
The deltoid muscle and the pattern of paresis in ALS	130
Neuromyelitis optica spectrum disorder with a familial Mediterranean fever gene E84K mutation	120
Microstructural characterization of multiple sclerosis lesion phenotypes using multiparametric longitudinal analysis	120
Tacrolimus-induced Parkinsonism	116
Interpretable deep learning survival predictions in sporadic Creutzfeldt–Jakob disease	100
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease	97
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case report	96
Neurological manifestation of HEV infection: still a rare disease entity?	82
Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report	71
Halting progressive multifocal leukoencephalopathy with pembrolizumab: the case of a patient with multiple sclerosis under fingolimod	68
The DeMyers: Marian (1922–2012) and William (1924–2008)	67
Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study	63
Pallidal deep brain stimulation for patients with myoclonus-dystonia without SGCE mutations	62
Richard Caton (1842-1926)	62
Tourette syndrome: effects of acetyl-leucine in two individuals	61
Increased aneurysm wall permeability colocalized with low wall shear stress in unruptured saccular intracranial aneurysm	60
Explaining recovery from coma with multimodal neuroimaging	60
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism	59
Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis	58
Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis	57
Incidence of Guillain–Barré syndrome in Cuba before and during the Oropouche virus emergency, 2018–2024	57
Dizziness and spatial disorientation in patients with transient global amnesia: clinical and vestibular correlates	55
Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management	53
Improving conscientiousness through a smartphone app and telecoaching intervention: insights from multiple sclerosis and healthy aging samples	51

Dystonia management across Europe within ERN-RND: current state and future challenges	50
Historical and current issues in HIV encephalitis, and the role of neuropathology in HIV disease: a pathological perspective	49
A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder	49
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis	49
TS-HDS autoantibody: clinical characterization and utility from real-world tertiary care center experience	48
Acute symptomatic seizures and hippocampal sclerosis: the major contributor for post-stroke epilepsy?	48
Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers	48
Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity	48
Complications of reversible cerebral vasoconstriction syndrome in relation to age	46
Longitudinal predictors of health-related quality of life in isolated dystonia	45
Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?	44
Hashimoto’s encephalopathy with diffuse leukoencephalopathy: serial MRI and gait analysis	44
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study	44
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy	43
A decision aid is not the quick fix for improving shared decision-making in advanced Parkinson’s disease: results of a mixed methods feasibility study	43
Exploring epigenetic modifications as potential biomarkers and therapeutic targets in amyotrophic lateral sclerosis	43
Correction to: Synergistic effects of vagus nerve stimulation and antiseizure medication	42